Dr. John S. Bynon Jr., MD

Dr. Bynon practices at Memorial Hermann-Texas Medical Center in Houston, Texas, part of Memorial Hermann Health System.

Dr. Bynon's NPI, 1386684918, was assigned on June 8, 2006. Dr. Bynon graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1985. Dr. Bynon holds Texas license P0352.

Dr. Bynon's primary practice is Memorial Hermann-Texas Medical Center, at 6411 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 704-3700.

Dr. Bynon's primary practice is Memorial Hermann-Texas Medical Center in Houston, Texas, part of Memorial Hermann Health System. The medical group on file is UT Physicians. Dmand AI also links Dr. Bynon to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bynon practices, 2 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Bynon's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. Bynon is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Bynon's licenses on file in 2 states: Texas and Alabama.

Dmand AI lists abdominal hernia repair surgery, esophagus, stomach, or upper small intestine surgery and kidney transplant among the conditions Dr. Bynon treats.

CMS data shows 31 Medicare services from Dr. Bynon across 2 procedure codes in 2023, for 27 Medicare patients. Medicare paid $37,124 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Bynon in 2024. The largest group is 65 to 74, with 11 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 4.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bynon's median patient age at 61, with 50% women.

In 2024, Dr. Bynon wrote 1,988 Medicare Part D claims for 215 patients. 84% of them were for generic drugs. CMS names the drug for 1,689 of them, across 41 drugs with 11 or more claims each, at $392,547 in total drug cost. In 2023, CMS named 1,813 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bynon for performance year 2024, reported as part of a group.

Dmand AI links 12 papers to Dr. Bynon, published from 2017 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Pancreatic Neoplasms and Postoperative Complications. Dr. Bynon has published most often in Open Forum Infect Dis. Dr. Bynon's most frequent co-authors are Aleksandra M. De Golovine, MD, David Ryan Hall, MD and Wasim A. Dar, MD.

Dmand AI links Dr. Bynon to 1 clinical trial. Conditions studied include Reperfusion Injury and Inflammation.

CMS Open Payments shows 26 general payments to Dr. Bynon from 9 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 64% of the total. Biom'Up SA paid the most, $6,187.

Dmand AI lists 2 awards for Dr. Bynon, most recently 2019 Honoree Houston Chapter ALF in 2019. Dr. Bynon serves on Network 14 MRB - ESRD.

Dr. Bynon graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1985. Dr. Bynon is a member of AASLD, AHPBA, ACS and Americian Society Transplant Surgeons.

Dr. Bynon is in network with 21 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.